Multiple Sclerosis Therapy

Multiple Sclerosis Therapy is a therapeutic intervention strategy within the domain of immunomodulatory drug therapy that specifically targets the modulation of immune responses to mitigate neuroinflammation and decelerate disease progression in individuals with multiple sclerosis.

8K

Publications

507K

Citations

30.9K

Authors

5.4K

Institutions

Publications per year

2017–2026

2.5K

Authors

30.9K

  1. LK
    Ludwig Kappos

    University Hospital of Basel, Switzerland

    240 publications · 39.9K citations

    88

    h-index

  2. XM
    Xavier Montalbán

    Vall d'Hebron Hospital Universitari, Spain

    182 publications · 25.2K citations

    68

    h-index

  3. EH
    Eva Havrdová

    Charles University, Czechia

    142 publications · 21.7K citations

    61

    h-index

  4. RG
    Ralf Gold

    St. Josef-Hospital, Germany

    126 publications · 14.1K citations

    59

    h-index

  5. CP
    Carlo Pozzilli

    Sapienza University of Rome, Italy

    133 publications · 9.3K citations

    57

    h-index

1–5 of 30.9K

Venues

  1. Neurology

    483 publications · 56.4K citations

    129

    h-index

  2. Multiple Sclerosis Journal

    MSJ · 801 publications · 42.7K citations

    97

    h-index

  3. Annals of Neurology

    148 publications · 24.8K citations

    83

    h-index

  4. Journal of Neurology Neurosurgery & Psychiatry

    162 publications · 12.2K citations

    64

    h-index

  5. Journal of Neurology

    213 publications · 11.6K citations

    59

    h-index

1–5